Genesis’ proprietary foundation model – Pearl – outperforms frontier models, including AlphaFold 3, on key benchmarks that predict utility in real-world drug discovery Pearl’s performance improved ...
The MarketWatch News Department was not involved in the creation of this content. -- Genesis' proprietary foundation model -- Pearl -- outperforms frontier models, including AlphaFold 3, on key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results